Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 195

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis

Open access
Chadi, Sami A, Malcomson, Lee, Ensor, Joie, Riley, Richard D, Vaccaro, Carlos A, Rossi, Gustavo L, Daniels, Ian R, Smart, Neil J, Osborne, Melanie E, Beets, Geerard L, Maas, Monique, Bitterman, Danielle S, Du, Kevin, Gollins, Simon, Sun Myint, Arthur, Smith, Fraser M, Saunders, Mark P, Scott, Nigel, O'Dwyer, Sarah T, de Castro Araujo, Rodrigo Otavio, Valadao, Marcus, Lopes, Alberto, Hsiao, Cheng-Wen, Lai, Chien-Liang, Smith, Radhika K, Paulson, Emily Carter, Appelt, Ane, Jakobsen, Anders, Wexner, Steven D, Habr-Gama, Angelita, Sao Julião, Guilherme, Perez, Rodrigo O, Renehan, Andrew G · 2018 · The Lancet Gastroenterology & Hepatology

Abstract

BACKGROUND In patients with rectal cancer who achieve clinical complete response after neoadjuvant chemoradiotherapy, watch and wait is a novel management strategy with potential to avoid major surgery. Study-level meta-analyses have reported wide variation in the proportion of patients with local regrowth. We did an individual participant data meta-analysis to investigate factors affecting occurrence of local regrowth. METHODS We updated search results of a recent systematic review by searching MEDLINE and Embase from Jan 1, 2016, to May 5, 2017, and used expert knowledge to identify published studies reporting on local regrowth in patients with rectal cancer managed by watch and wait after clinical complete response to neoadjuvant chemoradiotherapy. We restricted studies to those that defined clinical complete response using criteria equivalent to São Paulo benchmarks (ie, absence of residual ulceration, stenosis, or mass within the rectum on clinical and endoscopic examination). The primary outcome was 2-year cumulative incidence of local regrowth, estimated with a two-stage random-effects individual participant data meta-analysis. We assessed the effects of clinical and treatment factors using Cox frailty models, expressed as hazard ratios (HRs). From these models, we derived percentage differences in mean θ as an approximation of the effect of measured covariates on between-centre heterogeneity. This study is registered with PROSPERO, number CRD42017070934. FINDINGS We obtained individual participant data from 11 studies, including 602 patients enrolled between March 11, 1990, and Feb 13, 2017, with a median follow-up of 37·6 months (IQR 25·0-58·7). Ten of the 11 datasets were judged to be at low risk of bias. 2-year cumulative incidence of local regrowth was 21·4% (random-effects 95% CI 15·3-27·6), with high levels of between-study heterogeneity (I2=61%). We noted wide between-centre variation in patient, tumour, and treatment characteristics. We found some evidence that increasing cT stage was associated with increased risk of local regrowth (random-effects HR per cT stage 1·40, 95% CI 1·00-1·94; ptrend=0·048). In a subgroup of 459 patients managed after 2008 (when pretreatment staging by MRI became standard), 2-year cumulative incidence of local regrowth was 19% (95% CI 13-28) for stage cT1 and cT2 tumours, 31% (26-37) for cT3, and 37% (21-60) for cT4 (random-effects HR per cT stage 1·50, random-effects 95% CI 1·03-2·17; ptrend=0·0330). We estimated that measured factors contributed 4·8-45·3% of observed between-centre heterogeneity. INTERPRETATION In patients with rectal cancer and clinical complete response after chemoradiotherapy managed by watch and wait, we found some evidence that increasing cT stage predicts for local regrowth. These data will inform clinician-patient decision making in this setting. Research is needed to determine other predictors of a sustained clinical complete response. FUNDING None.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(18)30301-7

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 195

Metadata

Authors
Chadi, S. A., Malcomson, L., Ensor, J., Riley, R. D., Vaccaro, C. A., Rossi, G. L., Daniels, I. R., Smart, N. J., Osborne, M. E., Beets, G. L., Maas, M., Bitterman, D. S., Du, K., Gollins, S., Sun Myint, A., Smith, F. M., Saunders, M. P., Scott, N., O'Dwyer, S. T., de Castro Araujo, R. O., Valadao, M., Lopes, A., Hsiao, C.-W., Lai, C.-L., Smith, R. K., Paulson, E. C., Appelt, A., Jakobsen, A., Wexner, S. D., Habr-Gama, A., Sao Julião, G., Perez, R. O., & Renehan, A. G.
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2018-12
Volume
3
Issue
12
Pages
825-836
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W2896936894
Cited by
195
References
4
FWCI
2.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. https://app.cochat.ai/papers/10.1016/s2468-1253(18)30301-7
The paper
Chadi, S. A., Malcomson, L., Ensor, J., Riley, R. D., Vaccaro, C. A., Rossi, G. L., Daniels, I. R., Smart, N. J., Osborne, M. E., Beets, G. L., Maas, M., Bitterman, D. S., Du, K., Gollins, S., Sun Myint, A., Smith, F. M., Saunders, M. P., Scott, N., O'Dwyer, S. T., . . . Renehan, A. G. (2018). Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(18)30301-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.